Initiator Pharma A/S

Initiator Pharma A/S Gross Margin

Gross Margin of Initiator Pharma A/S (INIT.ST) as of Nov 16, 2026.

Gross Margin

-

Last updated:

Gross Margin of Initiator Pharma A/S is 2026 - . Gross Margin of Initiator Pharma A/S was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Initiator Pharma A/S Stock analysis

What does Initiator Pharma A/S do? Initiator Pharma A/S is a clinical-stage biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. The company develops novel therapeutics targeting monoamine reuptake transporters for central nervous system disorders, with a focus on erectile dysfunction treatments. Initiator Pharma A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Initiator Pharma A/S stock

On Eulerpool you can find the complete historical development of Gross Margin Initiator Pharma A/S since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Initiator Pharma A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Initiator Pharma A/S

All Key Metrics — Initiator Pharma A/S